Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

NCT07314905 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Influenza A
Influenza B
SAR-CoV-2
Acute Respiratory Infections (ARIs)

Interventions

DRUG: Baloxavir
DRUG: Placebo Control

Sponsor

Unity Health Toronto

Collaborators

[object Object]
[object Object]